Caricamento...
The pre-BCR to the rescue: therapeutic targeting of pre B cell ALL
Pre B-ALL is an aggressive cancer of the blood for which treatment of patients with relapsed and refractory disease remains a challenge (Bhatla et al., 2014). Here Geng et. al., surveyed activation status of the pre-B-cell receptor and comprehensively investigated downstream signaling mechanisms whi...
Salvato in:
| Pubblicato in: | Cancer Cell |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4532279/ https://ncbi.nlm.nih.gov/pubmed/25759017 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccell.2015.02.012 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|